{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:55:35Z","timestamp":1768582535799,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.7759\/cureus.101645","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:30:23Z","timestamp":1768541423000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapid Clearance of Refractory Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia With Septic Pulmonary Emboli Following Early Ceftaroline Therapy"],"prefix":"10.7759","author":[{"given":"Abhinav","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kavuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Ruhela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:e18-55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia. A review","volume":"312","author":"Holland TL","year":"2014","unstructured":"Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia. A review. JAMA. 2014, 312:1330-41. 10.1001\/jama.2014.9743","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein","volume":"190","author":"Fowler VG Jr","year":"2004","unstructured":"Fowler VG Jr, Sakoulas G, McIntyre LM, et al.. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis. 2004, 190:1140-9. 10.1086\/423145","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong SY","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015, 28:603-61. 10.1128\/CMR.00134-14","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160006","article-title":"Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"74","author":"White BP","year":"2017","unstructured":"White BP, Barber KE, Stover KR. Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Am J Health Syst Pharm. 2017, 74:201-8. 10.2146\/ajhp160006","journal-title":"Am J Health Syst Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak MJ","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al.. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020, 77:835-64. 10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete S","year":"2014","unstructured":"Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest. 2014, 124:2836-40. 10.1172\/JCI68834","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx084","article-title":"Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review","volume":"4","author":"Cosimi RA","year":"2017","unstructured":"Cosimi RA, Beik N, Kubiak DW, Johnson JA. Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review. Open Forum Infect Dis. 2017, 4:ofx084. 10.1093\/ofid\/ofx084","journal-title":"Open Forum Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai AD","year":"2022","unstructured":"Bai AD, Lo CK, Komorowski AS, et al.. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect. 2022, 28:1076-84. 10.1016\/j.cmi.2022.03.015","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad500","article-title":"Contemporary management of Staphylococcus aureus bacteremia-controversies in clinical practice","volume":"77","author":"Minter DJ","year":"2023","unstructured":"Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary management of Staphylococcus aureus bacteremia-controversies in clinical practice. Clin Infect Dis. 2023, 77:e57-68. 10.1093\/cid\/ciad500","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac137","article-title":"Approaching 65 years: is it time to consider retirement of vancomycin for treating methicillin-resistant Staphylococcus aureus endovascular infections?","volume":"9","author":"Rose W","year":"2022","unstructured":"Rose W, Volk C, Dilworth TJ, Sakoulas G. Approaching 65 years: is it time to consider retirement of vancomycin for treating methicillin-resistant Staphylococcus aureus endovascular infections?. Open Forum Infect Dis. 2022, 9:ofac137. 10.1093\/ofid\/ofac137","journal-title":"Open Forum Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452532-rapid-clearance-of-refractory-methicillin-resistant-staphylococcus-aureus-mrsa-bacteremia-with-septic-pulmonary-emboli-following-early-ceftaroline-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:30:23Z","timestamp":1768541423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452532-rapid-clearance-of-refractory-methicillin-resistant-staphylococcus-aureus-mrsa-bacteremia-with-septic-pulmonary-emboli-following-early-ceftaroline-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.101645","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}